Long-Term Management of Digestive Side Effects with GLP-1 Successfully managing digestive side effects, including sulphur burps, is crucial for maintaining adherence to GLP-1 therapy and achieving optimal treatment outcomes
Semaglutide, a type of GLP-1R agonists with 94% sequence homology to GLP-1 and with an extended half-life of approximately 1 week, has been clinically approved to treat T2DM and is available in subcutaneous and oral dosage form (136, 137)
Breaking Through a Weight Loss Plateau on Semaglutide: Next Steps If your weight loss stalled on Semaglutide , its time to take action
For glycemic control in patients with type 2 diabetes, less frequent dosing may lead to deterioration in blood glucose management
Type 2 diabetes is a condition involving high blood sugar (glucose) levels due to low insulin sensitivity , also known as insulin resistance